Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F8E1C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,094
Award facts
- Contract value 100% obligated
- $11,094.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,094.11 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose-2pen/ml pharmaceutical supply. This is a firm fixed price delivery order with no set-aside designation, issued on December 17, 2025, with an ultimate completion date of December 18, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's DLA contract portfolio demonstrates extensive capability to deliver specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency and other government healthcare systems. This delivery order for Cosentyx, an immunosuppressant used in treating conditions such as psoriasis and rheumatoid arthritis, exemplifies the company's role in supplying specialized pharmaceuticals to the military health system through the broader pharmaceutical prime vendor program structure.
Quick answers
Who was awarded contract SPE2DR26F8E1C?
SPE2DR26F8E1C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F8E1C worth?
The government has obligated $11,094 on SPE2DR26F8E1C.
Is contract SPE2DR26F8E1C an order under another contract?
Yes. SPE2DR26F8E1C is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8E1C competed?
The extent of competition for SPE2DR26F8E1C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award